(Q35194576)

7 August 2017

1 reference

title

Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment--final report (English)

1 reference

7 August 2017

Clifford Goodman

1

1 reference

7 August 2017

Stephen Chan

2

1 reference

7 August 2017

Patricia Collins

3

1 reference

7 August 2017

Randall Haught

4

1 reference

7 August 2017

Ying-Jun Chen

5

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

43

1 reference

7 August 2017

issue

8 Suppl

1 reference

7 August 2017

page(s)

3S-46S

1 reference

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

America's Blood Centers and the gift relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Epstein-Barr virus and cancers of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

The UK blood transfusion service: over a (patent) barrel?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Evidence-based recommendations for the use of WBC-reduced cellular blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Current status of solvent/detergent-treated frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Validating billing data for RBC transfusions: a brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

Safety of the blood supply in the United States: opportunities and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.43.8S.2.X

10.1046/J.1537-2995.43.8S.2.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference